Latest Breaking News On - Matinas biopharma holdings inc - Page 1 : comparemela.com

Investigation announced for Long-Term Investors in shares

Investigation announced for Long-Term Investors in shares
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Matinas biopharma holdings incMatinas biopharma holdings

Matinas BioPharma s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting

Matinas BioPharma s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJody cainJamesj fergusonMatinas biopharmaAmerican society of geneMatinas biopharma holdings incBiopharma holdingsChief medical officerNanocrystal deliveryInnate immuneHuman bloodSmall oligonucleotide deliveryBiologically activeTargeted oligonucleotidesLipid nanocrystalAmerican society

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

BEDMINSTER, N.J., May 02, 2024 Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal platform.

United statesJody cainMatinas biopharmaMatinas biopharma holdings incNational resilience incBiopharma holdingsPrivate securities litigation reform actNational resilience

Baystreet ca - Matinas Declines on Public Offering

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) shares fell Wednesday. The Bedminster, New Jersey-based company, a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery .

Matinas biopharma holdings incMatinas biopharma holdingsNew jersey based

Matinas BioPharma Prices $10 Million Registered Direct Offering

BEDMINSTER, N.J., April 03, 2024 Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal .

United statesNew yorkJody cainMatinas biopharmaSecurities exchangeMatinas biopharma holdings incCompany annual report on formExchange commissionA gp alliance global partnersBiopharma holdingsAlliance global partnersSecurities actSecurities exchange actPrivate securities litigation reform actAnnual report